Research Articles | Page 18 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes Aug 2017 Leukemia
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium Jan 2017 Leukemia myelodysplastic syndromes (MDS)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
Therapy-related Myelodysplastic Syndromes Deserve Specific Diagnostic Sub-Classification and Risk-Stratification-An Approach to Classification of Patients With t-MDS Jun 2020 Leukemia myelodysplastic syndromes (MDS)
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes May 2014 Leukemia myelodysplastic syndromes (MDS)
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria Jan 2021 Leukemia paroxysmal nocturnal hemoglobinuria (PNH)
Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS Jun 2020 Leukemia acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Application of the International Prognostic Scoring System-Revised (IPSS-R) in Therapy-related Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes Feb 2018 Leukemia myelodysplastic syndromes (MDS)
Share with addtoany.com.